Technetium (99mTc) tilmanocept is an injectable imaging agent that is used in the diagnostic imaging of lymph nodes. It is a small molecule that binds to specific proteins in the lymph nodes, making it easier to see them on imaging scans. It is typically used in combination with other imaging techniques such as computed tomography (CT) or magnetic resonance imaging (MRI) to provide a clearer view of the lymph nodes and the surrounding tissue. Technetium (99mTc) tilmanocept is especially useful for diagnosing metastatic cancer and for identifying the extent of spread of a tumor. It is also useful for detecting the presence of inflammation or infection in the lymph nodes.
Technetium (99mTc) tilmanocept, also known by the trade name Lymphoseek, is a radiopharmaceutical agent used in nuclear medicine for lymphatic system imaging. Here's a breakdown of its key features:
Components and Function:
- Technetium-99m (⁹⁹mTc): This is the radioactive component, a man-made isotope of technetium, which emits gamma rays used for imaging.
- Tilmanocept: This is a small synthetic molecule that acts as a targeting agent. It binds to specific receptors (mannose receptors) expressed on the surface of reticuloendothelial cells in lymph nodes.
Medical Use:
Technetium (99mTc) tilmanocept is primarily used for:
- Lymphatic Mapping: This technique helps identify and locate the sentinel lymph nodes (SLNs) in cancer patients. SLNs are the first lymph nodes to which cancer cells are likely to drain from a tumor. By mapping these nodes, surgeons can locate them during surgery and determine if cancer has spread to the lymphatic system.
- Guiding Sentinel Lymph Node Biopsy (SLNB): After lymphatic mapping with Tc-99m tilmanocept, surgeons can use a handheld gamma counter to precisely locate the SLNs during surgery. This allows for a more targeted biopsy, potentially reducing complications and recovery time.
Mechanism of Action:
- Injection and Targeting: Tc-99m tilmanocept is injected subcutaneously (under the skin) near the tumor site. Tilmanocept then binds to mannose receptors on lymphatic endothelial cells, which are involved in draining fluid from tissues.
- Lymph Node Accumulation: As lymph fluid drains from the tumor area, it carries Tc-99m tilmanocept along with it. The tilmanocept binds to mannose receptors on the surface of macrophages within the lymph nodes, causing them to accumulate the radioactive agent.
- Gamma Ray Detection: The gamma rays emitted by decaying Tc-99m are detectable by a gamma camera. This allows for the visualization of lymph nodes that have taken up Tc-99m tilmanocept, highlighting the SLNs that drain the tumor area.